bucindolol has been researched along with Decerebrate Posturing in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lukas, MA; Mitchell, MP; Ohlstein, EH; Ruffolo, RR; Willette, RN | 1 |
Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL | 1 |
2 other study(ies) available for bucindolol and Decerebrate Posturing
Article | Year |
---|---|
Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Decerebrate State; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Heart Failure; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Sympathomimetics | 1998 |
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol | 1999 |